FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Hi-Tech Pharmacal Acyclovir Oral Suspension Recall

Acyclovir Oral Suspension, USP 200 mg/5 mL

Hi-Tech Pharmacal Co., Inc. · Amityville, NY

Risk level
Class III
Reported by FDA
Jan 1, 2014
Recall ID
D-389-2014
Check your lot numberHow we source this data

Summary

Hi-Tech Pharmacal recalled Acyclovir Oral Suspension starting Oct 28, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-389-2014 on Jan 1, 2014. Reason: Failed Stability Specification; product viscosity and or pH are below specification. Status: Terminated.

Why it was recalled

Failed Stability Specification; product viscosity and or pH are below specification.

Product description

Acyclovir Oral Suspension, USP 200 mg/5 mL, Net Wt. 16 fl oz (473 mL), Rx only, Hi-Tech Pharmacal Co, Inc. Amityville, NY 11701. NDC 50383-810-16.

Lot numbers, UPCs & expiration codes

Batch no: 1) 614463 (exp. 03/2014), 2) 612905 (exp. 12/2013), 3) 614923 (exp. 03/2014), 4) 615852 (exp. 05/2014), 5) 615855 (exp. 05/2014), 6) 616689 (exp. 07/2014), 7) 616692 (exp. 07/2014).

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-389-2014
Classification
Class III
Status
Terminated
Recall initiated
Oct 28, 2013
FDA report date
Jan 1, 2014
Quantity
51.948 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hi-Tech Pharmacal Co., Inc.

Original FDA data

Every field from FDA enforcement report D-389-2014, exactly as published.

Show all FDA fields
City
Amityville
State
NY
Status
Terminated
Country
United States
Event ID
66675
Address
369 Bayview Ave
Code information
Batch no: 1) 614463 (exp. 03/2014), 2) 612905 (exp. 12/2013), 3) 614923 (exp. 03/2014), 4) 615852 (exp. 05/2014), 5) 615855 (exp. 05/2014), 6) 616689 (exp. 07/2014), 7) 616692 (exp. 07/2014).
Postal code
11701-2801
Report date
Jan 1, 2014
Product type
Drugs
Recall number
D-389-2014
Classification
Class III
Recalling firm
Hi-Tech Pharmacal Co., Inc.
Product quantity
51.948 bottles
Termination date
May 16, 2016
Reason for recall
Failed Stability Specification; product viscosity and or pH are below specification.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acyclovir Oral Suspension, USP 200 mg/5 mL, Net Wt. 16 fl oz (473 mL), Rx only, Hi-Tech Pharmacal Co, Inc. Amityville, NY 11701. NDC 50383-810-16.
Distribution pattern
Nationwide
Recall initiation date
Oct 28, 2013
Initial firm notification
Letter
Center classification date
Dec 24, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-389-2014, published Jan 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls